The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy

OBJECTIVES: To explore clinically relevant differences in severity of vulvar and vaginal atrophy (VVA) in postmenopausal women treated with ospemifene compared with placebo. METHODS: Analysis of two multicenter, randomized, double-blind, 12-week phase-III studies in postmenopausal women (40–80 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Nappi, R. E., Panay, N., Bruyniks, N., Castelo-Branco, C., De Villiers, T. J., Simon, J. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438339/
https://www.ncbi.nlm.nih.gov/pubmed/25335119
http://dx.doi.org/10.3109/13697137.2014.975199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438339/
https://www.ncbi.nlm.nih.gov/pubmed/25335119
http://dx.doi.org/10.3109/13697137.2014.975199

Ejemplares similares